Subscribe free

Newsletter

HPB & Spleen

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
BMC Gastroenterol30 May 2024

Inside Stent Placement Enhances Preoperative Biliary Drainage in Perihilar Cholangiocarcinoma

Inside stent placement for preoperative biliary drainage in perihilar cholangiocarcinoma patients showed significantly lower rates of recurrent biliary obstruction, longer stent patency, fewer replacements, and reduced hospital stays and costs compared to conventional stent placement. Additionally, inside stent placement resulted in fewer complications and lower…

Hepatol Int30 May 2024

Tertiary Lymphoid Structures Predict Survival in Combined Hepatocellular-Cholangiocarcinoma

High intratumoural tertiary lymphoid structure (TLS) score correlated with prolonged survival, while high TLS density in adjacent tissue indicated worse prognosis in combined hepatocellular-cholangiocarcinoma. Mature TLSS linked to favorable outcomes with more CD8+ T cell infiltration. TLSS distribution and density can predict prognosis and serve…

Int J Surg29 May 2024

Improved Efficacy and Safety with HARO-ALPPS Procedure for HCC Treatment

Novel HARO-ALPPS procedure significantly restricts hepatic artery blood supply post-surgery, enhancing liver regeneration in HCC patients with severe fibrosis. Results show superior outcomes in terms of mortality and liver function compared to conventional ALPPS procedure. Further studies required to confirm oncologic benefits of HARO-ALPPS in…

World J Gastrointest Oncol29 May 2024

Feasibility of Percutaneous Transhepatic Cholangioscopy-Assisted Biliary Polypectomy for Intraductal Papillary Neoplasm of the Bile Duct

Effective local palliative treatment of intraductal papillary neoplasm of the bile duct using percutaneous transhepatic cholangioscopy-assisted biliary polypectomy. Feasible, safe, and successful in five patients, with technical and therapeutic success achieved. Patients with mucin-hypersecreting cast-like or polypoid type tumors benefited, with no serious adverse events.…

Am J Surg Pathol28 May 2024

Revisiting Lesion Classification in Pancreatic Cancer: PanIN or IPMN?

3D imaging challenges traditional size-based classification of precancerous lesions in pancreatic ductal adenocarcinoma. Over 1400 lesions meeting size criteria for pancreatic intraepithelial neoplasia (PanIN) were identified in 3D analysis, with a quarter digitally sectioning as intraductal papillary mucinous neoplasms (IPMN). Half of these large lesions…

World J Gastrointest Oncol28 May 2024

Improving Prognosis in Pancreatic Head Cancer

TRIANGLE operation, combined with adequate adjuvant chemotherapy, can improve the prognosis of pancreatic head cancer. The triangle operation is safe for PDAC patients undergoing PD, reduces local recurrence rates, and may enhance patient survival with proper adjuvant chemotherapy support, according to a retrospective study. This…

J Hepatol27 May 2024

Association Between Liver Stiffness Changes and Risk of Liver-related Events in NAFLD

Increases and decreases in liver stiffness measurements independently predict liver-related events in NAFLD. Progression to higher stiffness levels was linked to a higher risk of liver events, while regression to lower levels decreased this risk. These findings highlight the clinical significance of monitoring liver stiffness…

BMC Surg27 May 2024

Impact of Arterial Coverage with Retromesenteric Omental Flap on Postpancreatectomy Hemorrhage

Arterial coverage with retromesenteric omental flap significantly reduces clinically relevant postpancreatectomy hemorrhage after pancreaticoduodenectomy. This novel technique, compared to no coverage, led to lower hemorrhage rates, fewer postoperative pancreatic fistulas, and decreased reoperation needs. Multivariate analysis confirmed the omental flap as an independent protective factor…

J Gastrointest Surg27 May 2024

Outcome Improvement with Transcatheter Arterial Embolization/Chemoembolization and Elective Hepatectomy for Ruptured Hepatocellular Carcinoma

Spontaneous rupture of hepatocellular carcinoma (RHCC) poses a major threat, with mortality rates ranging from 25-75%. Recent research highlights improved survival rates and reduced complications through a treatment combination of transcatheter arterial embolization/chemoembolization (TAE/TACE) followed by elective hepatectomy. Active surveillance efforts, advanced diagnostic tools, and…

Ann Surg Oncol26 May 2024

Robotic Right Hepatectomy with En Bloc Caudatectomy for Bismuth IIIa Hilar Cholangiocarcinoma

Minimally invasive robotic right hepatectomy with en bloc caudatectomy is safe and feasible for Bismuth IIIa hilar cholangiocarcinoma, with successful outcomes and minimal complications. The technique allows for radical resections and satisfactory postoperative recoveries, demonstrating a new surgical approach for challenging hepatic conditions. This approach…